Article Body
Advanced Enzyme Technologies shares fell around 7% on Monday after the company reported a mixed set of financial results for the first quarter. While revenue recorded modest growth year-on-year (YoY), net profit and EBITDA declined during the quarter.
Advanced Enzyme Q1 Results
Advanced Enzyme Technologies reported a 7% decline in consolidated net profit to ₹37 crore in Q1, compared with ₹40 crore in the corresponding quarter last year.
The company’s revenue from operations increased 2.1% YoY to ₹190 crore, compared with ₹186 crore a year earlier.
Meanwhile, EBITDA declined 9.9% to ₹51 crore from ₹56.6 crore in the year-ago period. The EBITDA margin also contracted to 26.9% from 30.4%, indicating pressure on operating profitability.
Advanced Enzyme Q1 Performance
| Particulars | Q1 FY26 | Q1 FY25 | YoY Change |
|---|---|---|---|
| Net Profit | ₹37 crore | ₹40 crore | Down 7% |
| Revenue | ₹190 crore | ₹186 crore | Up 2.1% |
| EBITDA | ₹51 crore | ₹56.6 crore | Down 9.9% |
| EBITDA Margin | 26.9% | 30.4% | Down 350 bps |
Advanced Enzyme Share Price
Advanced Enzyme shares declined around 7% as of 12:44 PM, following the Q1 results. The stock opened at ₹322.70, compared with the previous close of ₹324.35.
The stock touched an intraday low of ₹296.70 and a high of ₹322.70. Its 52-week low stands at ₹251.95, while the 52-week high is ₹419.00.
Comments